Sort
130,381 grants matching “hiv”
Development of Rectal Enema As Microbicide (DREAM)
$3,392,437Craig Walter Hendrix · Johns Hopkins University · U19 · FY2015 · AI
Durable Antibody Mediated Protection Against HIV
$3,389,755Robert C Gallo · University Of Maryland Baltimore · P01 · FY2019 · AI
Medical Directors Office
$3,388,915Giuseppe Giaccone · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
GH11-1104, IMPLEMENTATION & EXPANSION OF HIGH QUALITY HIV CARE, PREVENTION
$3,388,838Paul Wekesa · Centre For Health Solutions · U2G · FY2014 · GH
Statistical and Data Management Center (SDMC): Microbicide Trials Network
$3,387,468Elizabeth Renata Brown · Fred Hutchinson Cancer Research Center · UM1 · FY2014 · AI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,386,683Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Design and testing of immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$3,383,634Torben Schiffner · Scripps Research Institute, The · R01 · FY2025 · AI
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
$3,380,907Matthias Egger · Universitat Bern · U01 · FY2023 · AI
Primary Infection Resource Consortium (PIRC)
$3,380,278Susan Little · University Of California, San Diego · R24 · FY2021 · AI
Epidemiology and Natural History of Cancer-Associated Viruses
$3,379,228Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
THROUGH THE SEXUAL HIV PREVENTION FOR MOST-AT-RISK POPULATIONS/ VULNERABLE GROUPS AT CIVIL MILITARY INTERFACE SETTINGS IN ETHIOPIA II (TIMIR II)
$3,379,162Family Health International · · FY2016 · Defense Contract Management Agency
Development of an Effector-Memory T Cell AIDS Vaccine
$3,377,368Louis J. Picker · Oregon Health & Science University · P01 · FY2014 · AI
GH11-11108: TECHNICAL ASSISTANCE TO THE MOH FOR HIV SVC (PEPFAR)
$3,376,911Wafaa M. El-Sadr · Columbia University Health Sciences · U2G · FY2012 · GH
ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH
$3,375,299Sara Latrielle · International Ctr/Diarrhoeal Dis Res · U01 · FY2012 · CI
Women's Interagency HIV Study (WIHS-V)
$3,374,980Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2013 · AI
Global Health Comparative Effectiveness: A data synthesis method applied to HIV
$3,373,920James Gustave Kahn · University Of California, San Francisco · RC4 · FY2010 · AI
Durable Antibody Mediated Protection Against HIV
$3,373,790Robert C Gallo · University Of Maryland Baltimore · P01 · FY2018 · AI
Alphavirus Replicon Vaccines to Encephalitis Viruses
$3,373,441Alphavax Human Vaccines, Inc. · U01 · FY2005 · AI
THE ZIMBABWE-SAN FRANCISCO HIV PREVENTION TRIALS UNIT
$3,372,937University Of California San Francisco · U01 · FY2003 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$3,372,423Stephen A Spector · University Of California, San Diego · UM1 · FY2019 · AI
Mechanisms of protective immunity induced by live attenuated SIV vaccines
$3,370,567R. Paul Johnson · Harvard Medical School · P01 · FY2010 · AI
Translational Methamphetamine AIDS Research Center (TMARC)
$3,370,531Igor Grant · University Of California, San Diego · P50 · FY2011 · DA
Center for AIDS Research
$3,370,245David Mitchell Smith · University Of California, San Diego · P30 · FY2018 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$3,370,206Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2009 · AI
Increasing financial and health equity among low income black youth and young adults
$3,369,104Sheri Ann Lippman · University Of California, San Francisco · U01 · FY2021 · OD